Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection

Respirology

Volumn 15, Issue 1, 2010, Pages 126-131

  Enomoto, Tatsuji ^a   Azuma, Arata ^b   Kohno, Ayumi ^a   Kaneko, Kazuyo ^a   Saito, Hitoshi ^a   Kametaka, Minako ^a   Usuki, Jiro ^b   Gemma, Akihiko ^b   Kudoh, Shoji ^b   Nakamura, Seiichi ^a  

^a TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

CD4+ lymphocyte count; Human immunodeficiency virus infection; Immunosuppression; Pneumocystis; Pneumonia; Prophylaxis

Indexed keywords

PREDNISOLONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; MALE; MEDICAL RECORD; MORTALITY; NEUTROPHIL COUNT; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; DIABETES MELLITUS; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; LUNG DISEASES; MALE; MIDDLE AGED; NEUTROPHILS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TREATMENT OUTCOME;

EID: 74049094321     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01660.x     Document Type: Article

References (22)

1. D' Avignon LC, Schofield CM, Hospenthal DR. Pneumocystis pneumonia. Semin. Respir. Crit. Care. Med. 2008 29 : 132 140.
2. Saba R, Travis A, Michelle U et al. Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003. BMC Infect. Dis. 2008 8 : 118 127.
3. Chechani V, Brigges A. Pneumocystis carinii pneumonia in patients with connective tissue disease. Chest 1992 101 : 375 378.
4. Sepkowitz KA. Pneumocystis carinii pneumonia among patients with neoplastic disease. Semin. Respir. Infect. 1992 7 : 114 121.
5. Varthalitis I, Aoun M, Daneau D et al. Pneumocystis carinii pneumonia in patients with cancer. An increasing incidence. Cancer 1993 71 : 481 485.
6. Ewig S, Bauer T, Schneider C et al. Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients. Eur. Respir. J. 1995 8 : 1548 1553.
7. Mansharamani NG, Garland R, Delaney D et al. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985-1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000 118 : 704 711.
8. Monnet X, Vidal-Petiot E, Osman D et al. Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection. Crit. Care 2008 12 : R28.
9. Hughes WT, Kuhn S, Chaudhary S et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N. Engl. J. Med. 1977 297 : 1419 1426.
10. CDC. Recommendation for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR Recomm. Rep. 1992 41 (RR-4 1 11.
11. Enomoto T, Azuma A, Matsumoto A et al. Preventive effect of sulfamethoxasole-trimethoprim on Pneumocystis jiroveci pneumonia in patients with interstitial pneumonia. Intern. Med. 2008 47 : 15 20.
12. Kovas JA, Hiemenz JW, Macher AM et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann. Intern. Med. 1984 100 : 663 671.
13. Mansharamani NG, Balachandran D, Vernovsky I et al. Peripheral blood CD4+ T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest 2000 118 : 712 720.
14. Arend SM, Kroon FP, van't Wout JW. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. Arch. Intern. Med. 1995 155 : 2436 2441.
15. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo. Clin. Proc. 1996 71 : 5 13.
16. Masur H, Ognibene FP, Yarchoan R et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 1989 111 : 223 231.
17. Giuck T, Geerdes-Fenge HF, Straub RH et al. Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy. Infection 2000 28 : 227 230.
18. Pareja JG, Garland R, Koziel H. Use of adjunctive corticosteroids in severe adults non-HIV Pneumocystis carinii pneumonia. Chest 1998 113 : 1215 1224.
19. Su YS, Lu JJ, Perng CL et al. Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection. J. Microbiol. Immunol. Infect. 2008 41 : 478 482.
20. Boumpas DT, Chrousos GP, Wilder RL et al. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann. Intern. Med. 1993 119 : 1198 1208.
21. Cupps TR, Gerrard TL, Falkoff RJ et al. Effects of in vitro corticosteroids on B cell activation, proliferation and differentiation. J. Clin. Invest. 1985 75 : 754 756.
22. Vidal S, de la Horra C, Martin J et al. Pneumocystis Jurovecii colonization in patients with interstitial lung disease. Clin. Microbiol. Infect. 2006 12 : 231 235.